What's in Isarna Therapeutics GmbH's pipeline?

Isarna Therapeutics GmbH has 5 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 2 in Phase 1.

Which companies overlap with Isarna Therapeutics GmbH's portfolio?

Top competitors by shared drug class: Avidity Biosciences, Inc., Bristol-Myers Squibb, Celgene, European Organisation for Research and Treatment of Cancer - EORTC, Ionis Pharmaceuticals, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/isarna-therapeutics-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Isarna Therapeutics GmbH — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Isarna Therapeutics GmbH pipeline: 0 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 3 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Avidity Biosciences, Inc. · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
Celgene · 1 shared drug class
European Organisation for Research and Treatment of Cancer - EORTC · 1 shared drug class
Ionis Pharmaceuticals, Inc. · 1 shared drug class
Leadiant Biosciences, Inc. · 1 shared drug class
NYU Langone Health · 1 shared drug class
Sarepta Therapeutics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Isarna Therapeutics GmbH:

Cite this brief

Drug Landscape (2026). Isarna Therapeutics GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/isarna-therapeutics-gmbh. Accessed 2026-05-18.